Company: BIAF
Filing Date: 2025-09-30
Form Type: 424B4
Source: 0001493152-25-016338
Chunk: 3

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-09-30
Form: 424B4
Chunk 3
---
 offering. See “Plan of Distribution” beginning on page 27 of this prospectus for more information regarding these arrangements.

On September 17, 2025, we filed with the Secretary
of State of the State of Delaware a certificate of amendment to our certificate of incorporation to effect a one-for-thirty (1-for-30)
reverse split of our issued and outstanding shares of Common Stock. The Reverse Stock Split became effective as of 4:01 p.m. Eastern
Time on September 18, 2025, and our Common Stock began trading on a split-adjusted basis when Nasdaq opened on September 19, 2025. All
share and per share information in this prospectus (other than in the historical financial statements incorporated herein by reference)
has been adjusted to reflect the reverse stock split.

Investing in our securities involves a high degree of risk. See “Risk Factors” beginning on page9 of this prospectus for a discussion of information that should be considered in connection with an investment in our securities. Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

|                                    |     | Per   
 Share |      |     | Per Pre-Funded 
 Warrant        |       |     | Total |              |
|:-----------------------------------|:----|:------|-----:|:----|:---------------|------:|:----|:------|-------------:|
| Public offering price              |     | $     | 2.50 |     | $              | 2.493 |     | $     | 4,798,284.03 |
| Placement Agent fees(1)            |     | $     | 0.20 |     | $              | 0.199 |     | $     |   383,862.72 |
| Proceeds to us, before expenses(2) |     | $     | 2.30 |     | $              | 2.294 |     | $     | 4,414,421.31 |

| (1) | We                                                                                                                                   
 have agreed to pay the Placement Agent a cash fee equal to 8.0% of the aggregate gross proceeds raised in this offering. We have     
 also agreed to pay the Placement Agent for its legal fees and expenses and other out-of-pocket expenses in an amount up to $120,000. 
 We refer you to